Sign In to Follow Application
View All Documents & Correspondence

Iron Doped Manganese Oxide Nanoparticles And Method Of Preparation Thereof

Abstract: The present disclosure relates to a iron-doped manganese oxide nanoparticles comprising: MnO2:xFe3+ wherein, x=2, 4, 6, 8, and 10, and Fe is doped in MnO2 in presence of Tridax procumbens extract. The present disclosure also relates to a method of preparation of an iron-doped manganese oxide nanoparticles comprising: a) dissolving 5 to 15 mM of manganese salt precursor and 0.1 to 1 mM of iron salt precursor in water to obtain a first mixture; b) adding Tridax procumbens extract dropwise in the first mixture with constant stirring to obtain a second mixture; c) heating the second mixture with continuous stirring to obtain a nanoparticles; d) subjecting the nanoparticles to centrifugation to obtain a centrifuged nanoparticles; e) washing the centrifuged nanoparticles with a solvent to obtain a washed nanoparticles; and f) drying the washed nanoparticles followed by calcination to obtain an iron-doped manganese oxide nanoparticles.

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
18 April 2025
Publication Number
19/2025
Publication Type
INA
Invention Field
CHEMICAL
Status
Email
Parent Application

Applicants

Amrita Vishwa Vidyapeetham
Amrita Vishwa Vidyapeetham, Mysuru Campus, #114, 7th Cross, Bogadi II Stage, Mysuru, Karnataka - 570026, India.

Inventors

1. MAJANI, Sanjay S
No. 31/1, 5th Main, 8th Cross, Vinayaknagar, Mysuru - 570012, Karnataka, India.
2. KOLLUR, Shiva Prasad
No. 38, Sanatan, Tamarind Grove, Mysuru - 570026, Karnataka, India.

Specification

Description:FIELD OF THE INVENTION
[0001] The present disclosure relates to a technical field of nanomaterials and inorganic chemistry. More particularly, the present disclosure relates to an iron-doped manganese oxide nanoparticles. Further, the present disclosure also relates to a method of preparation of an iron-doped manganese oxide nanoparticles.

BACKGROUND OF THE INVENTION
[0002] Background description includes information that may be useful in understanding the present invention. It is not an admission that any of the information provided herein is prior art or relevant to the presently claimed invention, or that any publication specifically or implicitly referenced is prior art.
[0003] The growing pollution of water bodies due to pharmaceutical contaminants, particularly antibiotics, has emerged as a significant environmental issue [Baaloudj et al., Organics, 2025, 6, 1; Liu et al., Water, 2025, 17, 85]. Phase 1 focuses on a group of widely used antibiotics from the tetracycline class. Among them, Tetracycline Hydrochloride (TC-HCl) is one of the most commonly detected antibiotics in aquatic environments due to incomplete metabolism and improper disposal. Its persistence in water systems poses significant ecological risks, including the promotion of antibiotic-resistant bacteria, which threaten both environmental and public health. Consequently, the presence of TC-HCl in wastewater has garnered considerable scientific attention in recent years [Larcombe et al., Reviews in Aquaculture, 2025, 17, e12948; Verma et al., Current Analytical Chemistry, 2025, 21, 15-56]. Photocatalysis is an advanced oxidation process, which has shown great potential for the degradation of recalcitrant organic contaminants, such as antibiotics [Nan et al., Colloids and Interfaces, 2025, 9, 3; Roostaee et al., Materials Science in Semiconductor Processing, 2025, 188, 109212; Wang et al., Water, Air, & Soil Pollution 236, 30 (2024)].
[0004] Photocatalysts are vital for environmental remediation and energy uses, employing light-assisted reactions to power sustainable chemical processes [Vinayagam et al., Applied Nanoscience, 2023, 13, 847-857]. They efficiently break down organic contaminants in wastewater, such as antibiotics and dyes, avoiding ecological damage and antimicrobial resistance [Fan et al., ACS Materials Letters, 2025, 7, 1085-1111]. Increasing water source contamination requires effective photocatalytic treatment. In addition to wastewater treatment, photocatalysts are important in air purification, hydrogen generation, and antimicrobial uses [Ningthoukhongjam et al., International Journal of Hydrogen Energy, 2025, 113, 133-146]. They are also utilized in self-cleaning surfaces, CO₂ mitigation, and chemical sensing. They are of significant importance in accelerating reactions when exposed to light, making them critical for green technology, advancing environmental sustainability, and advanced material research [Vinayagam et al., Environmental Research, 2023, 216, 114766]. Hence, the design of advanced photocatalysts that are efficient, economical, and environmentally friendly is of utmost importance for tackling this challenge.
[0005] MnO2 is one of the transition metal oxides that possess multiple polymorphs and has garnered interest as a photocatalyst. This compound, having outstanding redox properties [Liang et al., Environmental Science: Nano, 2025, 12, 1364-1374] and environmental compatibility along with being abundant [ShekoftehNarm et al., Journal of Molecular Structure, 2025, 1320, 139678], finds considerable attention as a photocatalyst [Hosseini et al., Scientific Reports, 2025, 15, 866; karami et al., Results in Chemistry, 2025, 13, 102018; Boyom-Tatchemo et al., Catalysis Letters, 2024, 155, 8]. However, pristine MnO2 often faces challenges of lower photocatalytic efficiency mainly because of its relatively higher electron-hole recombination rate and suboptimal light absorption. Various strategies have been developed to overcome such limitations. Some of the approaches adopted are doping with foreign ions, surface modification, and introduction of nanostructures. Doping MnO2 with transition metal ions such as Fe3+ proved particularly effective in modulating electronic structure thereby enhancing charge carrier dynamics in promoting photocatalytic performance [Devarajan, BioNanoScience, 2024, 15, 149; Pan et al., Coordination Chemistry Reviews, 2025, 522, 216231].
[0006] The introduction of Fe3+ into MnO2 enhances its photoactivity. It possesses extra functionalities beyond this, i.e., stronger adsorption strength and extended photosensitivity into the visible region, making Fe3+-doped MnO2 a highly prospective material for application in the degradations of antibiotics. Recent researchers have found that Fe3+-doped MnO2 can be very effective in degrading many organic pollutants [Faramawy et al., Ceramics, 2025, 8, 2; Morais et al., Catalysis Letters, 2024, 155, 6]. However, most of these materials are synthesized by conventional chemical routes that depend on the use of toxic reducing agents and extreme reaction conditions [Irfan et al., New Journal of Chemistry, 2025, 49, 2308-2318]. This is not only environmentally adverse but also problematic for sustainable and scalable production [Shen et al., Separation and Purification Technology, 2025, 353, 128529; Rozina et al., Next Energy, 2025, 7, 100218].
[0007] To overcome these drawbacks, green synthesis methods have become popular as an alternative to nanomaterial preparation. Bio-reduction, using plant extracts or other biological agents as reducing and stabilizing agents, is one of the promising routes for nanostructure synthesis with eco-friendliness and sustainability [Redjili et al., Industrial Crops and Products, 2025, 223, 120168]. Using plant extracts to synthesize photocatalysts enhances their physicochemical properties by introducing bioactive compounds that help achieve controlled morphology, improved crystallinity, and increased surface area, which are vital for efficient light absorption and separation of charge carriers [Kadhem et al., Biomass Conversion and Biorefinery, 2024, 14, 24655-24669]. Additionally, the addition of phytochemicals influences defect states and oxygen vacancies, leading to greater photocatalytic performance due to improved dynamics of electron-hole pairs and the formation of reactive species [Gbair et al., Biomass Conversion and Biorefinery, 2024, 14, 28117-28132; Sumethra et al., Materials Science and Engineering: B, 2025, 313, 117958]. One of the main advantages of using plant extracts is that they are rich in phytochemicals such as flavonoids, phenolic acids, and alkaloids, which act naturally as reducing agents [Islam et al., Journal of Future Foods, 2025, 5, 1-20; Mehra et al., BioNanoScience, 2024, 15, 18]. This approach eliminates the need for toxic chemicals, conserves energy, and aligns with the principles of green chemistry. Furthermore, nanomaterials synthesized through this method possess unique physicochemical properties, such as increased surface area and improved crystallinity, making them highly valuable for catalytic applications.
[0008] Thus, there is a need to develop a novel iron-doped manganese oxide nanoparticles without the use of toxic chemical.

OBJECTIVES OF THE INVENTION
[0009] An object of the present disclosure is to provide an iron-doped manganese oxide nanoparticles.
[0010] Another objective of the present disclosure is to provide a method of preparation of an iron-doped manganese oxide nanoparticles.
[0011] Still another objective of the present disclosure is to develop novel nanoparaticle for effective photo-accelerated detoxification of tetracycline.
[0012] Yet another objective of the present disclosure is to provide an eco-friendly and sustainable approval for nanomaterial fabrication.

SUMMARY OF THE INVENTION
[0013] This summary is provided to introduce a selection of concepts in a simplified form that are further described below in Detailed Description section. This summary is not intended to identify key features or essential features of the claimed subject matter, nor is it intended to be used as an aid in determining the scope of the claimed subject matter.
[0014] An aspect of the present disclosure relates to an iron-doped manganese oxide nanoparticles comprising: MnO2:xFe3+ wherein, x=2, 4, 6, 8, and 10, and Fe is doped in MnO2 in presence of Tridax procumbens extract.
[0015] Another aspect of the present disclosure relates to a method of preparation of an iron-doped manganese oxide nanoparticles comprising: a) dissolving 5 to 15 mM of manganese salt precursor and 0.1 to 1 mM of iron salt precursor in water to obtain a first mixture; b) adding Tridax procumbens extract dropwise in the first mixture with constant stirring to obtain a second mixture; c) heating the second mixture with continuous stirring to obtain a nanoparticles; d) subjecting the nanoparticles to centrifugation to obtain a centrifuged nanoparticles; e) washing the centrifuged nanoparticles with a solvent to obtain a washed nanoparticles; and f) drying the washed nanoparticles followed by calcination to obtain an iron-doped manganese oxide nanoparticles.
[0016] Other aspects of the invention will be set forth in the description which follows, and in part will be apparent from the description, or may be learnt by the practice of the invention.

BRIEF DESCRIPTION OF THE DRAWINGS
[0017] The accompanying drawings are included to provide a further understanding of the present disclosure and are incorporated in and constitute a part of this specification. The drawings illustrate exemplary embodiments of the present disclosure and, together with the description, serve to explain the principles of the present disclosure.
[0018] FIG. 1 illustrates the mechanism involved in the photocatalyst.
[0019] FIG. 2 illustrates (A) UV-Visible absorption spectra of MF (0-10) samples, (B) corresponding Tauc plot evaluating band gap energies, and (C) transition mechanism responsible for absorption band of MF (0-10) samples.
[0020] FIG. 3 illustrates (a) PXRD patterns of MnO2: xFe3+ (x=0, 2, 4, 6, 8, and 10 mol%) aligning with pristine and Fe3+ doped Manganese Oxide cards, #96-151-4120 and 96-900-8069, respectively. (b) W-H Plot of MnO2: xFe3+ (x=0, 2, 4, 6, 8, and 10 mol%).
[0021] FIG. 4 illustrates Rietveld refinement and extracted crystal structure of (a, b) MnO2 and (c, d) MnO2: 10 mol% Fe3+ samples.
[0022] FIG. 5 illustrates (a, b) and (c, d) 2D and 3D electron density map in the unit cell of MnO2 and MnO2: 10 mol% Fe3+ samples, respectively.
[0023] FIG. 6 illustrates Recorded Raman spectra of MnO2: xFe3+ (x=0, 2, 4, 6, 8, and 10 mol%) samples.
[0024] FIG. 7 illustrates recorded hysteresis curve of MF-10 sample from VSM analysis.
[0025] FIG. 8 illustrates FESEM images of pristine MnO2 (a-d) and MnO2: 10 mol% Fe3+ (e-h) samples at 2 μm, 1 μm, and 500 nm magnifications. (i and j) Long-normal particle size distribution curve of MF0 and MF10, respectively.
[0026] FIG. 9 illustrates scanned area for elemental analysis and its corresponding EDAX spectrum of MnO2 (A) and MnO2: 10 mol% Fe3+ (B) samples.
[0027] FIG. 10 illustrates TEM images of as-prepared MnO2: 10 mol% Fe3+ sample at (a-e) 500 nm, 200 nm, 100 nm, 50 nm, and 20 nm magnification, respectively, (f and e) HRTEM images, and (h) SAED image.
[0028] FIG. 11 illustrates (a) N2 adsorption-desorption isotherm curve, (b) BET adsorption plot, and (c) pore size distribution curve of as-obtained MF-10 sample.
[0029] FIG. 12 illustrates qualitative and quantitative elemental XPS analysis of as-prepared MnO2: 10 mol% Fe3+ sample. (a) overall spectra and (b-e) deconvoluted individual Mn 2p, Fe 2p, O 1s, and C 1s peaks.
[0030] FIG. 13 illustrates dosage-dependent TC-HCl removal percentage against irradiation time (a), 1st-order kinetics plot of TC-HCl degradation (b), trapping agent test (c), and pHPZC evaluation (d).
[0031] FIG. 14 illustrates pH effect on removal percentage (a) and reusability test of the recovered photocatalyst (b).
[0032] FIG.15 illustrates FESEM images recorded after recovering the MF-10 sample from the degradation process of 1st-cycle.
[0033] FIG.16 illustrates PXRD (a) and FTIR (b) results of MF-10 photocatalyst before and after recycling.

DETAILED DESCRIPTION OF THE INVENTION
[0034] The following is a detailed description of embodiments of the disclosure depicted in the accompanying drawings. The embodiments are in such detail as to clearly communicate the disclosure. However, the amount of detail offered is not intended to limit the anticipated variations of embodiments; on the contrary, the intention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the present disclosure as defined by the appended claims.
[0035] Each of the appended claims defines a separate invention, which for infringement purposes is recognized as including equivalents to the various elements or limitations specified in the claims. Depending on the context, all references below to the "invention" may in some cases refer to certain specific embodiments only. In other cases, it will be recognized that references to the "invention" will refer to subject matter recited in one or more, but not necessarily all, of the claims.
[0036] Unless the context requires otherwise, throughout the specification which follow, the word “comprise” and variations thereof, such as, “comprises” and “comprising” are to be construed in an open, inclusive sense that is as “including, but not limited to.”
[0037] Reference throughout this specification to “one embodiment” or “an embodiment” means that a particular feature, structure or characteristic described in connection with the embodiment is included in at least one embodiment. Thus, the appearances of the phrases “in one embodiment” or “in an embodiment” in various places throughout this specification are not necessarily all referring to the same embodiment. Furthermore, the particular features, structures, or characteristics may be combined in any suitable manner in one or more embodiments.
[0038] As used in this specification and the appended claims, the singular forms “a,” “an,” and “the” include plural referents unless the content clearly dictates otherwise. It should also be noted that the term “or” is generally employed in its sense including “and/or” unless the content clearly dictates otherwise.
[0039] In some embodiments, the numbers expressing quantities of ingredients, properties such as concentration, reaction conditions, and so forth, used to describe and claim certain embodiments of the invention are to be understood as being modified in some instances by the term “about.” Accordingly, in some embodiments, the numerical parameters set forth in the written description are approximations that can vary depending upon the desired properties sought to be obtained by a particular embodiment. In some embodiments, the numerical parameters should be construed in light of the number of reported significant digits and by applying ordinary rounding techniques. Notwithstanding that the numerical ranges and parameters setting forth the broad scope of some embodiments of the invention are approximations, the numerical values set forth in the specific examples are reported as precisely as practicable. The recitation of ranges of values herein is merely intended to serve as a shorthand method of referring individually to each separate value falling within the range.
[0040] Unless otherwise indicated herein, each individual value is incorporated into the specification as if it were individually recited herein. All methods described herein can be performed in any suitable order unless otherwise indicated herein or otherwise clearly contradicted by context. The use of any and all examples, or exemplary language (e.g. “such as”) provided with respect to certain embodiments herein is intended merely to better illuminate the invention and does not pose a limitation on the scope of the invention otherwise claimed. No language in the specification should be construed as indicating any non-claimed element essential to the practice of the invention.
[0041] The headings and abstract of the invention provided herein are for convenience only and do not interpret the scope or meaning of the embodiments.
[0042] Reference will now be made in detail to the exemplary embodiments of the present invention, examples of which are illustrated in the accompanying drawings.
[0043] The following description provides different examples and embodiments of the inventive subject matter. Although each embodiment represents a single combination of inventive elements, the inventive subject matter is considered to include all possible combinations of the disclosed elements. Thus, if one embodiment comprises elements A, B, and C, and a second embodiment comprises elements B and D, then the inventive subject matter is also considered to include other remaining combinations of A, B, C, or D, even if not explicitly disclosed.
[0044] All percentages, ratios, and proportions used herein are based on a weight basis unless otherwise specified.
[0045] Various terms as used herein are shown below. To the extent a term used in a claim is not defined below, it should be given the broadest definition persons in the pertinent art have given that term as reflected in printed publications and issued patents at the time of filing.
[0046] The present disclosure provides a synthesis of MnO2:xFe3+ (MF-x, x=2, 4, 6, 8, and 10) nanoparticles via the bio-mediated process using Tridax procumbens as the reducing and stabilizing agents. Various physicochemical approaches confirmed the structural, optical, and morphological properties of MF-x nanoparticles, revealing a reduced optical bandgap (2.06-0.97 eV) for visible-light photocatalysis. PXRD analysis reveals cubic crystalline nature of MF-x nanoparticles belonging to space group number 206 (I a-3) with crystallite sizes ranging 39-70 nm, which was further refined using Rietveld method with acceptable χ2 value of 2.3 for the doped sample. Raman spectra confirmed the existence of Fg and Eg+Fg active modes from the bixbyite structure corresponding to the space group I a-3. Furthermore, the FESEM and TEM analyses showed a highly crystalline uniform porous morphology with evaluated particle sizes in agreement with the PXRD results. Additionally, the quantitative aspects of precursor elements are confirmed through XPS studies. The photocatalytic activity of MF-10 in degrading Tetracycline hydrochloride (TC-HCl) is evaluated under optimized pH, catalyst dosage, and TC-HCl concentration under visible light. Results show that optimized weight (100 mg) of as-synthesized nanoparticles exhibit high photocatalytic performance with a 94.23% degradation against optimized 20 ppm TC-HCl in 90 mins. On the other hand, pH variation and reusability test indicated that the degradation efficiency is significant at neutral pH and reduced at the 5th cycle (64.28) which was further authenticated by pHPZC evaluation (7.55). Thus, the present disclosure showcased the potential application of MnO2: Fe3+ nanoparticles as low-cost and environmentally friendly material in water treatment applications.
[0047] Among various potential candidates, Tridax procumbens is selected for its rich phytochemical composition and well-documented biological properties. Tridax procumbens, commonly known as coat buttons, is a medicinal plant widely distributed in tropical and subtropical regions. Its extracts are rich in flavonoids, tannins, saponins, and phenolic compounds, which not only serve as reducing agents but also contribute to the degradation of organic pollutants through additional reactive oxygen species (ROS) generation. Flavonoids and phenolic acids are known to enhance the photocatalytic activity of nanomaterials by stabilizing the nanoparticles and facilitating charge transfer. The antimicrobial and antioxidant properties of Tridax procumbens further enhance its utility in wastewater treatment, making it an ideal choice for the green synthesis of photocatalysts.
[0048] The present disclosure presents the pioneering use of Tridax procumbens leaf extract as a novel bio-reducing agent in the green synthesis of Fe3+-doped MnO2 nanostructures, establishing an eco-friendly and sustainable approach for nanomaterial fabrication. The as-synthesized MnO2: Fe3+ nanostructures exhibited remarkable photocatalytic efficiency in the degradation of Tetracycline, highlighting their potential for applications in wastewater treatment. The enhanced degradation performance is attributed to the synergistic effects of Fe³⁺ doping combined with the unique physicochemical properties imparted by the green synthesis method. The present disclosure expands the possibilities for bio-inspired nanomaterial synthesis and provides a sustainable strategy to address antibiotic contamination in aquatic environments.
[0049] An embodiment of the present disclosure provides an iron-doped manganese oxide nanoparticles comprising: MnO2:xFe3+ wherein, x=2, 4, 6, 8, and 10, and Fe is doped in MnO2 in presence of Tridax procumbens extract.
[0050] In some embodiment, the nanoparticles has a particle size ranging from ……..to……nm.
[0051] An embodiment of the present disclosure provides a method of preparation of an iron-doped manganese oxide nanoparticles comprising: a) dissolving 5 to 15 mM of manganese salt precursor and 0.1 to 1 mM of iron salt precursor in water to obtain a first mixture; b) adding Tridax procumbens extract dropwise in the first mixture with constant stirring to obtain a second mixture; c) heating the second mixture with continuous stirring to obtain a nanoparticles; d) subjecting the nanoparticles to centrifugation to obtain a centrifuged nanoparticles; e) washing the centrifuged nanoparticles with a solvent to obtain a washed nanoparticles; and f) drying the washed nanoparticles followed by calcination to obtain an iron-doped manganese oxide nanoparticles.
[0052] In some embodiment, the manganese salt precursor is selected from a group comprising of manganese (II) acetate tetrahydrate, ………………..and combination thereof and wherein the iron salt precursor is selected from a group comprising of iron (III) nitrate nonahydrate, ………………..and combination thereof. Preferably, the manganese salt precursor is manganese (II) acetate tetrahydrate and the iron salt precursor is iron (III) nitrate nonahydrate.
[0053] In some embodiment, the Tridax procumbens extract is prepared by the steps comprising: suspending 15 to 20 % w/v of shade dried Tridax procumbens leaves in water to obtain a suspension; heating the suspension at a temperature ranging from 60 to 100 °C for a time period ranging from ……..to……hrs to obtain a concentrated suspension; and cooling the concentrated suspension to a temperature ranging from 15 to 35 °C followed by filtering the cooled concentrated suspension to obtain a Tridax procumbens extract. Preferably, the amount of dried Tridax procumbens leaves are suspended in water is 16 to 19 % w/v or 17 to 18 % w/v. The preferable heating temperature of suspension is 70 to 90 °C or 80 °C for a preferable time period of …to…or …….hrs.
[0054] In some embodiment, the heating condition in step c) includes temperature ranging from 60 to 100 °C for a time period ranging from……….to……..hrs. Preferably, the heating temperature is 70 to 90 °C or 80 °C for a time period ranging from……….to……..hrs or ……hrs respectively.
[0055] In some embodiment, the centrifugation in step d) is carried out at a speed ranging from 8000 to 12000 rpm for a time period ranging from 10 to 20 min at a temperature ranging from 15 to 35 °C. Preferably, the speed is 9000 to 11000 rpm for a time period of 12 to 18 min at a temperature of 15 to 30 °C. More preferably, the speed is 10000 rpm for a time period of 15 min at a temperature of 20 to 30 °C.
[0056] In some embodiment, the solvent is selected from a group comprising of ethanol, ……………………. and combination thereof. Preferably, the solvent is ethanol.
[0057] In some embodiment, the drying in step f) includes temperature ranging from 60 to 100 °C for a time period ranging from 2 to 6 hrs. Preferably, the drying temperature is 70 to 90 °C or 80 °C for a time period of 3 to 5 hrs or 4 hrs respectively.
[0058] In some embodiment, the calcination in step f) is carried out at a temperature ranging from 500 to 700 °C for a time period ranging from 1 to 5 hrs. Preferably, the calcination temperature is 600 °C for a time period of 3 hrs.
[0059] All chemicals required to perform the present study were purchased from commercial vendors and used without further purification unless specified; Manganous (II) acetate tetrahydrate ((CH3COO)2Mn · 4H2O) (Merck, ≥98%) and Ferric (III) nitrate nonahydrate (Fe(NO3)3·9H2O) (Merck, ≥98%) and Deionised water (Merck Millipore). Structural, morphological, optical, and surface characteristics of as-synthesized nanoparticles were investigated by employing different sophisticated techniques. Phase purity and crystal structure were analyzed by powder X-ray diffraction (PXRD) with the help of a Bruker D8 Advance diffractometer. Surface functional groups were determined by Fourier transform infrared (FTIR) spectroscopy with the aid of a SHIMADZU IRTracer-100. Optical characteristics, such as band-gap analysis, were investigated by employing a SHIMADZU UV 3600 PLUS UV-Vis spectrophotometer. Raman spectral analysis was conducted on a WITec Alpha 300RA Raman spectrometer. The morphological features and elemental composition were examined using field emission scanning electron microscopy (FESEM) and energy-dispersive X-ray spectroscopy (EDS) on a TESCAN MAIA3 XMH microscope. Transmission electron microscopy (TEM) was carried out on a JOEL JEM-2100 instrument to identify the particle size and lattice fringes. The magnetic characteristics were studied on a Lake Shore 8600 Series vibrating sample magnetometer (VSM). X-ray photoelectron spectroscopy (XPS) was conducted on a PHI Genesis Fully Automated Multi-Technique Scanning XPS/HAXPES Microprobe from Physical Electronics to study the oxidation states and surface chemical composition. The Brunauer–Emmett–Teller (BET) surface area and porosity were measured with an Autosorb iQ-x instrument from Quantachrome. Furthermore, the total organic carbon (TOC) concentration was measured through the use of a SHIMADZU TOC-L Series analyzer.
[0060] The characterization data were analyzed using various software tools to ensure accurate interpretation. The PXRD data were analyzed using HighScore Plus 3.0.5, PANalytic B.V. Almelo, The Netherlands. Rietveld Refinements were performed through FullProf Suite. FESEM and TEM images were analyzed for morphology using ImageJ, a free software. All the RAW data from the characterization was analyzed and processed for graphical representation using OriginPro, Version 2024. OriginLab Corporation, Northampton, MA, USA.
[0061] The catalytic efficiency of the prepared MF-x samples under visible light irradiation in degrading TC-HCl was evaluated using the degradation set-up equipped with a 150 W metal halide lamp with ~2600 W/m2 irradiance. Initially, the experiment starts with preparing 3 distinct 20 ppm (20 mg/L) TC-HCl solutions using doubly-distilled water and mixing it with a properly weighed selected photocatalyst, MF-x samples in respective concentrations of 50 mg, 75 mg, and 100 mg. The mixture was then allowed to acquire adsorption-desorption equilibrium in the dark for 30 min. Further, the mixture was illuminated with visible light with the wavelength >420 nm from all directions. 2.5 mL of mixture solution was pipetted out every 10 minutes and centrifuged at 8000 rpm to record the UV-visible spectrum and study the characteristic wavelength at 361 nm. Furthermore, the recorded spectra were utilized in evaluating the degradation efficiency using the relation (1),
-------------- (1)
Where A0 and At indicate initial absorbance and absorbance at a particular time t. Similar procedure were employed in evaluating the mechanism by conducting trapper test. Scavengers like Na2SO4, C6H8O6 (ascorbic acid), TEOH (triethanolamine), methanol, and isopropanol were used in distinct degradation solution to evaluate the degradation rate. Further, reusability of the recovered photocatalyst was checked every cycle until recycled for the 5th time.
[0062] The possible degradation mechanism (FIG. 1) of TC-HCl under photocatalytic conditions involves the generation of ROS where •O2⁻ radical is considered the major species. Light absorption by the photocatalyst excites electrons from the valence band to the conduction band with energies higher or equal to the band gap, creating an electron-hole pair (e⁻/h⁺). The photogenerated electrons react with O₂ adsorbed on the catalyst's surface, forming •O2⁻ radicals. Concurrently, holes (h⁺) will oxidize water or hydroxyl ions (OH⁻) and give hydroxyl radicals (•OH).
[0063] The •O2⁻ radicals, being the main reactive species, initiate degradation of TC-HCl molecules through oxidative attack, degrading complex molecular structures into smaller intermediates. Further, degradation is enhanced by •OH and other species formed in the process that further oxidize the intermediates into simpler end products such as CO2 and H2O. The mechanism is further supported by trapper experiments that revealed a strong diminution in the photocatalytic activity when particular scavengers were used, specifically those targeting •O2⁻. The importance of superoxide radicals in facilitating the degradation process effectively is underscored. The suggested mechanism can be summarized through the following steps,

[0064] Adsorption of antibiotics on the surface of the photocatalyst might facilitates the degradation process by promoting their interaction with the reactive species. Here, drug adsorption onto the photocatalyst plays a prominent role in degrading TC-HCl. Adsorption improves the accessibility of the drug molecules for oxidative or photocatalytic degradation and thus enhances the efficiency of the process. Prolonged contact time further results in strong adsorption, with improved bond cleavage and mineralization of the antibiotic contaminants.
[0065] Completely degrading antibiotics does not imply that mineralization of TC-HCl has occurred, and CO2 and H2O have been formed; thus, in the present disclosure, the mineralization of TC-HCl by the MF-10 sample is studied by measuring TOC elimination. The results reveal a significant 73.36% mineralization of TC-HCl at 7.35 mg/L. This indicates that the complete mineralization of TC-HCl in the photocatalytic process will take more time than the photocatalytic elimination of TC-HCl. This occurrence might be due to the formation of various products that compete with TC molecules.
[0066] While the foregoing describes various embodiments of the disclosure, other and further embodiments of the disclosure may be devised without departing from the basic scope thereof. The invention is not limited to the described embodiments, versions or examples, which are included to enable a person having ordinary skill in the art to make and use the invention when combined with information and knowledge available to the person having ordinary skill in the art.

EXAMPLES
[0067] The present disclosure is further explained in the form of the following examples. However, it is to be understood that the examples are merely illustrative and are not to be taken as limitations upon the scope of the invention. Various changes and modifications to the disclosed embodiments will be apparent to those skilled in the art. Such changes and modifications may be made without departing from the scope and spirit of the present invention.
Example 1
(i) Collection of Tridax procumbens leaves
[0068] With the help of a botanist, healthy T. procumbens leaves were collected from agricultural fields near Tavarekere, Bangalore, Karnataka, India that are regionally identified as Addike soppu / Attige soppu / Gabbu sanna shavanthi / Netta gabbu shavanthi. Selected leaves were separated, and washed with sterile distilled water to remove the surface adhered dust particles, ensuing taxonomical authentication by a Botanist. Collected leaves were then shade-dried in a dust-free environment overnight to remove moisture.
(ii) Preparation of Tridax procumbens leaf extract
[0069] The Tridax procumbens L. extract was prepared using a standard extraction method. Twenty-five grams (25 g) of shade-dried Tridax procumbens leaves were suspended in 150 mL of double distilled water taken in a 250 mL conical flask and boiled to 80°C for about 30 min until the water was reduced to half of its initial volume. The resulting greenish brown extract was cooled and filtered through Whatman filter paper No. 1. Obtained filtrate was stored in a sealed container under 4°C until further use.
(iii) Synthesis of pristine MnO2 and MnO2:Fe3+ NPs using Tridax procumbens leaf extract
[0070] Synthesis of MnO2: xFe3+ (x=0.2 mmol) nanoparticles was carried out via the green synthetic route using Tridax procumbens leaf extract. Stoichiometric quantities of manganese (II) acetate tetrahydrate (2.4018 g) (Merck, ≥98%) (9.7 mM) and iron (III) nitrate nonahydrate (0.0808 g) (Merck, ≥98%) (0.2 mM) were dissolved in 100 mL of deionized water. To this, the prepared plant extract was added dropwise under constant stirring. The mixture was heated at 80°C with continuous stirring until the colour changed from greenish red to brownish black. This change indicated the completion of doping and the formation of nanoparticles. The obtained nanoparticles were then subjected to centrifugation at 10,000 rpm for 15 min at room temperature (about 15-35°C). Further washed with absolute ethanol (3×) to remove any unbound materials, dried in an oven at 80°C for 4 h and calcined at 600°C for an additional 3 h, resulting in brownish-black nano oxides. Once cooled to room temperature (about 15-35°C), the obtained nano oxide was designated as MF-2. A similar method was used to obtain pristine MnO2 nanoparticles and a series of Fe-doped MnO2 nanoparticles with different ratios of Fe(NO3)3·9H2O (0.0, 0.4, 0.6, 0.8, and 1.0 mmol), and samples were abbreviated as MF-0, MF-4, MF-6, MF-8, and MF-10, respectively. Detailed information about the precursor quantities is tabulated in Table 1.

Table 1: Quantitative information of precursor quantities.
Sample abbreviation Wt. of C4H6MnO4.H2O (in grams) Wt. of Fe(NO)3.9H2O (in grams)
Mole ratio Percentage
Mn Fe
MF-0 2.4509 g 0.0000 g 0.01: 0.00 100% 0%
MF-2 2.4018 g 0.0808 g 0.0097: 0.0002 98% 2%
MF-4 2.3528 g 0.1616 g 0.0095: 0.0004 96% 4%
MF-6 2.3038 g 0.2424 g 0.0093: 0.0006 94% 6%
MF-8 2.2548 g 0.3232 g 0.0091: 0.0008 92% 8%
MF-10 2.2058 g 0.4040 g 0.0089: 0.001 90% 10%

(iv)Characterizations of prepared iron-doped manganese oxide nanoparticles
(A) Band-gap studies
[0071] Electronic transitions and band gap evaluations were done by recording the UV-visible (UV-vis) absorption spectra of the synthesized pristine MnO2 and Fe³⁺-doped MnO2 nanoparticles over a range of 200-1200 nm. The absorption spectrum of pristine MF0 (FIG. 2A) showed a broad peak at around 265–480 nm, which was attributed to the charge transfer transitions involving the Oxygen 2p orbitals in the valence band and Manganese 3d orbitals in the conduction band. The most pronounced absorption in this range is assigned to oxygen-to-manganese charge transfer prevailing in this wavelength range and showing an efficient photoexcitation of electrons from the valence to the conduction band.
[0072] Doping with Fe3⁺ ions caused significant changes in the absorption spectrum. Except for the MF0 absorption, samples MF-2 to MF-10 had another band extending into the visible region; the onset is slightly red-shifted for the doped sample compared to the pristine MnO2 sample. The shift might be caused by mid-gap defect states brought by Fe3⁺ ions which allow further electronic transitions. These mid-gap states allow both metal-to-metal charge transfer transitions (Mn → Fe) and d-d transitions within the Fe3⁺ ions, which together enhance the absorption in the visible region. The red-shift and broadening of the absorption band indicate a reduction in the bandgap energy from 2.06 eV to 0.97 eV after Fe3⁺ doping as observed in FIG. 2B. The obtained results of decrement in band-gap with increasing Fe3+ concentration. The detailed electronic transition mechanism is shown in FIG. 2C. This, in turn, implies Fe3+ doped MnO2 nanoparticles can use a larger segment of the solar spectrum making them suitable for photocatalytic and optoelectronic applications. Electronic defect states through Fe3⁺ aptly modify the electronic structure thus enhancing the material's ability to absorb visible light and therefore optoelectronics performance under various multifunctional applications.
(B) Structural assessments
[0073] Structural assessments for the as-prepared samples were done by recording PXRD spectra between the 2θ range of 20° and 70°. FIG. 3(a) demonstrates the PXRD patterns MF-(0-10) samples exhibiting a perfect match for JCPDS file #96-151-4120 for MF-0 and #96-900-8069 for MF-10. The phase attainment results reveal that there is no major change in the phase before and after incorporating the Fe3+ ions into the host MnO2. All the as-prepared samples exhibited a perfect match with the cubic phase. The lattice parameters of MF-0 and MF-10 samples are tabulated in Table 2, which show no major change but a slight variation in unit-cell lengths. Major peaks detected at 2θ=23.00°, 32.77°, 38.15°, 45.09°, 49.33°, 55.13°, and 65.76° were assigned with (211), (222), (400), (332), (431), (440), and (622) hkl values, respectively. The average crystallite sizes of each sample were evaluated by substituting the same obtained peak values in Scherrer’s relation (2):
----------------(2)
Where; 0.9, is the shape factor on assuming circular shape, Dc, λ, and βhkl refer to crystallite size, wavelength of the X-rays used, and Full Width at Half Maximum (FWHM) of the selected peaks. The evaluated results show a crystallite size range of 39-74 nm. The same was affirmed in plotting the Williamson-Hall relation (3) for each pristine and doped sample as depicted in FIG. 3(b).
------------------(3)
Where; ε refers to the strain component. The results are tabulated in Table 3, affirming a significant increment in the crystallite size after incorporating the Fe3+ ions at the Mn2+ sites. The rationale behind this increment is lattice strain relaxation, where strain created upon incorporating the Fe3+ ions is saturated with the increment in the crystallite size. The same was observed in the strain component.
Table 2: Lattice parameters information from phase attainment analysis.

Parameters Values
#96-151-4120 (MF-0) #96-900-8069 (MF-10)
Crystal system Cubic Cubic
Space group I a-3 I a-3
Space group number 206 206
α (°) 90 90
β (°) 90 90
γ (°) 90 90
a (Å) 9.4080 9.4000
b (Å) 9.4080 9.4000
c (Å) 9.4080 9.4000

Table 3: Crystallite size, strain, and Refractive index evaluation of prepared samples.
Sample Crystallite size (nm) Strain component (ε) Band gap energy (Eg) (in eV)
Scherrer’s WH Plot
MF-0 39.92 42.16 0.02722 2.06
MF-2 60.21 63.47 0.04964 1.73
MF-4 73.37 75.12 0.04722 1.63
MF-6 68.24 70.28 0.04829 1.08
MF-8 62.86 65.18 0.04867 1.23
MF-10 70.13 72.68 0.04926 0.97

[0074] For more quantitative phase information of the samples, Rietveld refinement was conducted using FullProf suite software utilizing the JCPDS file #96-151-4120 for MF-0 and #96-900-8069 for MF-10. FIGs. 4 (a and b) show good agreement with the selected JCPDS files for the respective samples’ PXRD pattern with the refinement parameters tabulated in Table 4. FIG. 4 (c and d) represent the extracted structure of MF-0 and MF-10 samples using Diamond-5 software.
Table 4: Phase refinements parameters from the Rietveld method.
Refinement parameters #96-151-4120 (MF-0) #96-900-8069 (MF-10)
Rp 75.2 73.7
Rwp 81.5 80.0
Rexp 47.85 52.75
χ2 2.9 2.3
GOF 1.70 1.51

[0075] Furthermore, for extended information about the electron distribution inside the unit cell, the GFourier tool in FullProf was utilized in mapping electrons. This analysis, performing Fourier Transforms on structural factors throughout the unit cell, presents the atomic locations inside the unit cell. FIG. 5 depicts the 2D and 3D electron density mapping of the prepared MF-0 and MF-10 samples.
(C) Raman analysis
[0076] Raman analysis, an efficient technique used for more insights about the vibrational properties of the materials, was utilized to record the spectrum of prepared pristine and Fe3+ doped MnO2 nanoparticles. The bixbyite structural type matching with the PXRD data has a cubic phase with Ia-3 space group and 22 Raman active modes with the description of 4Ag + 4Eg +14Fg, 10 inactive modes 5Au + 5Eu, and 16 Tu IR modes. With so many Raman active modes (22), the number of modes appearing in the Raman spectrum is reduced. FIG. 6 shows the spectrum ranging between 100 cm-1 to 1600 cm-1 Raman shift revealing the prominent strong and weak bands at 632.43 cm-1 and 313 cm-1. Considering the above-discussed crystallographic symmetry, the bixbyite structural type explains all the Raman active modes in the spectrum consistent with the result obtained from XRD. Bands are broad too, which contradicts the expectation since the calculated crystallite size is larger as discussed in the PXRD section. The characteristic bands observed at 632.43 cm-1 and 313 cm-1 correspond to Fg and Eg+Fg modes linking to Mn-O vibrations as labeled in the FIG. 6. Furthermore, the presence of Fe3+ in the structure is highlighted by the peak broadening observed in the spectrum attributed to the changes in the force constants and vibrational amplitudes of neighboring peaks.
(D) Magnetic properties
[0077] Measurements using vibrating sample magnetometry (VSM) were used to examine the magnetic characteristics of the nanoparticles, including remanence, coercivity, and saturation magnetization. The hysteresis loop (FIG. 7), obtained for the MF-10 sample from the VSM analysis, showed a remnant magnetization (Mr) of 33.42 emu/g and a saturation magnetization (Ms) of 65.11 emu/g at 15 kOe. This validated the nanoparticles' strong magnetic properties. A coercivity (Hc) value of 1393.47 Oe demonstrated their susceptibility to external magnetic fields, with the detection of reversible magnetization transformations.
(E) Morphology
[0078] FIG. 8 (a-h) represents the FESEM images of prepared MF-0 (a-d) and MF-10 (e-h) extending over 2 μm to 500 nm magnification range. As seen in the images the MF0 sample exhibits a network-like morphology consisting of various shapes with a particle size averaging at ~39 nm (FIG. 8i). After incorporating Fe3+ ions into the MnO2, the MF10 sample exhibits a porous network-like morphology with an averaging particle size at ~71 nm (FIG. 8j). The significant porotic changes to the morphology can be aligned with the successful incorporation of Fe3+ ions. Furthermore, a prominent qualitative elemental analysis over a selected area of MF0 and MF10 samples was conducted and imaged as it is in FIG. 9 (A, and B), respectively. The results observed affirm the precursor elements with a Gold (Au) contamination from the sputtering process.
[0079] Also, confirming the morphology and crystallinity, TEM analysis was conducted on the MF10 sample as depicted in FIG. 10 (a-h). TEM images affirm the different shapes (rod, smooth-edge cube, and sharp crystal-end) networked morphology which aligns with FESEM results. Lattice spacing and crystallinity were also assured through HRTEM and SAED images as depicted in FIGs. 10 (g and h), respectively.
(F) Surface Area Analysis
[0080] The MF-10 sample was evaluated for its surface area, pore volume, and pore size through BET surface area analysis conducted at 160 °C for 2 hours. In FIG. 11 (a), the adsorption/desorption isotherm curve is displayed alongside the pore size distribution of the synthesized MF-10 sample. The N2 adsorption and desorption data confirmed that the material exhibits a type II isotherm with an H3 hysteresis loop, aligning with the classification established by the International Union of Pure and Applied Chemistry (IUPAC). This indicates the sample's mesoporous characteristics. FIG. 11 (b) depicts the determined BET surface area, average pore radius, and overall pore volume were recorded as 19853 m²/g, 3.691 nm, and 0.043 cm³/g, respectively. According to IUPAC standards, porous materials are classified according to their pore size (d) as microporous (d < 2 nm), mesoporous (2 nm < d < 50 nm), and macroporous (d > 50 nm). FIG.11 (c) illustrates the pore size distribution, which highlights a significant peak at 3.691 nm, further confirming the material's mesoporous nature.
(G) Surface composition analysis
[0081] XPS measurements were done on the MF-10 sample to examine the quantitative chemical composition and oxidation states of the precursor elements. FIG. 12 (a) depicts the recorded XPS survey spectra between the binding energy range of -10-1350 eV, affirming all the precursor elements in the sample. Furthermore, the Shirley-type background function was utilized in deconvoluting the high-resolution peaks of the respective elements.
[0082] As illustrated in FIG.12 (b), the fit of the Mn 2p core-level high-resolution XPS spectra contains two distinct peaks: those at 641.51 eV and 653.18 eV. The Mn 2p3/2 and Mn 2p1/2 peaks occur at about 641.0 eV and 652.4 eV binding energies, respectively, and indicate Mn3+ ions with a spin-orbit splitting of approximately 11.4 eV. FIG. 12 (c) presents a high-resolution Fe 2p spectrum, which also distinctly depicts the Fe 2p1/2 and Fe 2p3/2 photoelectron peaks of two different oxidation states. Spectrum fitting was optimized on two PL for each Fe 2p component deconvoluted into a combination of Gaussian-Lorentzian peak lines. The resulting doublets had BEs at 710.87 eV and 724.44 eV, attributing to Fe 2p1/2 and Fe 2p3/2, respectively. Furthermore, high-resolution O 1s and C 1s show their respective prominence peaks at 729.72 eV and 284.72 eV, as depicted in FIG. 12(d) and 12(e).
Example 2: Degradation of TC-HCl antibiotic
[0083] TC-HCl antibiotic degradation was conducted in a series of experiments. FIG. 13 (a) depicts the photocatalyst dosage effect on the degrading efficiency (%) of TC-HCl from the solution. The results yielded the efficiency (%) of 74.86%, 84.87%, and 94.23% for 50 mg, 75 mg, and 100 mg proportions, respectively after 90 minutes of visible light irradiation. The same results were analyzed for degradation kinetics using the pseudo-1st-order relation,
------------------(4)
Where A0 and At indicate initial absorbance and absorbance at a particular time t. k1 refers to the rate constant of the 1st-order reaction. The degradation results suggest a good agreement with the selected 1st-order kinetics (FIG. 13b) with the parameters listed in Table 5.
Table 5: Degradation kinetics parameters of TC-HCl antibiotic.
Parameters 50 mg 75 mg 100 mg
k1 0.0093 0.012 0.014
R2 0.97 0.96 0.96
(A) pHPZC and trapper evaluation
[0084] The pH drift method was adopted to determine the pHPZC of the as-prepared MF-10 sample in the presence of 0.1N NaCl electrolyte solution. The pH of the solution was varied stepwise between 2 and 12 with the help of 0.1N NaOH and 0.1N HCl solutions. 50 mL of 0.1 N NaCl was filled in a conical flask with 0.10 g of MF-10 sample. This mixture was shaken at 150 rpm for 24 hours to attain pH equilibrium. The difference (∆pH) in the pH values obtained between the final and initial (pHi) values was plotted against the initial pH values. The pHPZC value was determined from the x-axis intersection of this curve. FIG. 13 (c) indicates that the pHPZC of MF-10 is 7.55.
[0085] The trapper test was employed for the determination of reactive species participating in the photocatalytic reaction using scavengers like Na2SO4, C6H8O6 (ascorbic acid), TEOH (triethanolamine), methanol, and isopropanol. The selective additives of the reactants utilized as scavengers assist in quenching some ROS or radicals in the photocatalytic reaction process. In the current study, Na2SO4 was an electron scavenger, ascorbic acid a quencher of superoxide radicals (•O2⁻), and TEOH, methanol, and isopropanol as hole (h⁺) and hydroxyl radicals (•OH) traps, respectively. The test was performed by introducing a known quantity of each scavenger into the photocatalytic system under identical conditions, with subsequent monitoring of the effect on photocatalytic degradation efficiency. The results observed in FIG. 13 (d) revealed the maximum effect on degradation efficiency was observed for ascorbic acid, suggesting the primary suspect as •O2⁻ responsible for the photocatalytic degradation of TC-HCl
(B) pH variation and reusability test
[0086] The influence of the variation in pH on the photodegradation efficacy of TC-HCl was studied to understand the conditions of acidic, neutral, and basic pH variations on the photocatalytic degradation reaction. It was done by initially adjusting the reaction mixture to obtain specific values of pH (pH 3, 5, 7, 9, and 12) before initiating the process of photocatalysis under identical experimental conditions using dilute HCl and NaOH, respectively. The efficiency of degradation was assessed by evaluating the absorbance of TC-HCl at its wavelength of interest using UV-Vis spectroscopy at equal intervals. Results depicted in FIG. 14 (a) shows that the maximum degradation efficiency of 94.26% was obtained at pH nearing 7. This confirms that neutral conditions facilitate the photocatalytic reaction. This study underlines the influence of pH on the surface charge of the photocatalyst, the ionization state of TC-HCl, and the generation of reactive species, which are all together affecting the degradation performance.
[0087] Evaluation of reusability was carried out through repeated TC-HCl degradation cycles conducted under identical conditions of experimentation (FIG. 14b). The photocatalyst recovered by the centrifugation after each cycle washed sufficiently with distilled water and allowed to dry could be reused again for the successive cycle. Photocatalytic degradation efficiency results are presented in up to five continuous cycles to see whether the activity and stability are sustained or reduced during these periods. The results have a gradual decay in efficiency and, at a point, exhibited 92.15% degradation in the 2nd cycle, 89.56% in the 3rd cycle, 70.27% in the 4th cycle, and 64.28% in the 5th cycle. These declines may result from the degradation of active sites or aggregation of catalysts and other structural degradations due to repeated use. These results showed that photocatalysts do possess some prospect in their potential use for real applications with little decline in activity following repeated runs.
[0088] Furthermore, the MF-10 sample centrifuged after the 1st-cycle of the degradation process was evaluated for morphology changes after interacting with TC-HCl. The results observed in FIG. 15 (a-c) showcase no significant change in the networked morphology except for the disappearance of the porous structure after interacting with the antibiotic TC-HCl. This is attributed to the improved stability of the sample even after cycle 1 of the degradation process. The results of the current catalyst are compared with the results of various catalysts against different antibiotics, which have been briefed in Table 6.
Table 6: Comparison of current MF-10 with various Photocatalyst
Sl. No. Photocatalyst Antibiotics and
Degradation (%) References
1. Fe doped TiO2–Bi2O3 nanocomposite Cephalexin (74%) Abdeyazdan et al., Sci. Rep., 2025, 15, 8824.
2. CuAl2O4-Cu-Bi4O5Br2 Nanocomposite Tetracycline (95.2%)
Doxycycline (95.7%)
Tetracycline + Doxycycline (95.4%) Subhiksha et al., J. Taiwan Inst. Chem. Eng., 2025, 169, 105952
3. CeO2: Au Nanoparticles

Tetracycline (86.4%)
Ciprofloxacin (57.7%) Huang et al., J Environ Manag 2025, 379, 124893
4. Ag2O Nanoparticles Ciprofloxacin (46%) Tabassum et al., New J Chem, 2025, 49, 1301-1313
5. CuFe2O4 nanoparticles Tetracycline (95.8%) Dinesh et al., Results in Chemistry, 2025, 13, 102037
6. MnO2: Fe3+ Nanoparticles Tetracycline (94.26%) This work

Example 3: Stability Assessment of Photocatalyst
[0089] The pre-and post-degradation structural stability of the photocatalyst was assessed by recording the PXRD pattern and FTIR spectra of the initial and recovered MF-10 sample. The PXRD results showcased in FIG. 16 (a) reveal the stable cubic structure of MF-10 photocatalyst even after degrading the TC-HCl for 90 mins. The same was observed in the FTIR results except for a small intensity drop at 1113.78 cm-1 (FIG. 16b) which was attributed to the absorption factor experienced by the catalyst. These findings suggest no change in chemical or structural aspects of the MF-10 photocatalyst even after recovering it after 90 minutes of degradation.
[0090] The foregoing examples are merely illustrative and are not to be taken as limitations upon the scope of the invention. Various changes and modifications to the disclosed embodiments will be apparent to those skilled in the art. Such changes and modifications may be made without departing from the scope of the invention.

ADVANTAGES OF THE INVENTION
[0091] The MnO2: xFe3+ (MF-x, x= 2, 4, 6, 8, and 10) nanoparticles are successfully prepared using the bio-reduction method with the help of leaf extract of Tridax procumbens as a capping agent.
[0092] The optical band gap of the as-synthesized MF-x catalysts has been calculated to be in the range of 2.06-0.97 eV, which proves the catalysts to be suitable for photocatalytic activity under visible light.
[0093] The cubic crystalline structure identified by PXRD is also supported by Rietveld refinement with the crystallite size within the range of 39 to 74 nm.
[0094] The FESEM and TEM results also showed that the surface of the synthesized catalysts had a porous structure, and the particle sizes are in accordance with the presence of PXRD, the results of elemental and components and XPS analysis properly confirmed Fe3+ ions doping into the MnO2 lattice.
[0095] Among the catalysts prepared, MF-10 demonstrated the highest photocatalytic activity, achieving 94.23% degradation of Tetracycline Hydrochloride (TC-HCl) within 90 minutes of visible light irradiation.
[0096] The photocatalytic process followed first-order kinetics, and optimization of parameters such as pH and catalyst dosage highlighted the potential for wastewater treatment using these catalysts. Although degradation efficiency decreased after the fifth cycle, the catalysts maintained strong initial degradation efficiency under neutral pH conditions, indicating their promising potential for real-world applications. Also, a significant 73.36% mineralization of TC-HCl achieved was authenticated by TOC analysis. The structural stability of the photocatalyst after the degradation was assessed through PXRD and FTIR analysis, which reveal no changes after 90 mins of TC-HCl degradation.
[0097] The bio-mediated MnO₂: Fe³⁺ nanoparticles are identified as an environmentally friendly and cost-effective solution to address environmental challenges.


, Claims:1. An iron-doped manganese oxide nanoparticles comprising:
MnO2:xFe3+
wherein, x=2, 4, 6, 8, and 10, and
Fe is doped in MnO2 in presence of Tridax procumbens extract.
2. The iron-doped manganese oxide nanoparticles as claimed in claim 1, wherein the nanoparticles has a particle size ranging from ……..to……nm.
3. A method of preparation of an iron-doped manganese oxide nanoparticles comprising:
a) dissolving 5 to 15 mM of manganese salt precursor and 0.1 to 1 mM of iron salt precursor in water to obtain a first mixture;
b) adding Tridax procumbens extract dropwise in the first mixture with constant stirring to obtain a second mixture;
c) heating the second mixture with continuous stirring to obtain a nanoparticles;
d) subjecting the nanoparticles to centrifugation to obtain a centrifuged nanoparticles;
e) washing the centrifuged nanoparticles with a solvent to obtain a washed nanoparticles; and
f) drying the washed nanoparticles followed by calcination to obtain an iron-doped manganese oxide nanoparticles.
4. The method as claimed in claim 3, wherein the manganese salt precursor is selected from a group comprising of manganese (II) acetate tetrahydrate, ………………..and combination thereof and wherein the iron salt precursor is selected from a group comprising of iron (III) nitrate nonahydrate, ………………..and combination thereof.
5. The method as claimed in claim 3, wherein the Tridax procumbens extract is prepared by the steps comprising:
suspending 15 to 20 % w/v of shade dried Tridax procumbens leaves in water to obtain a suspension;
heating the suspension at a temperature ranging from 60 to 100 °C for a time period ranging from ……..to……hrs to obtain a concentrated suspension; and
cooling the concentrated suspension to a temperature ranging from 15 to 35 °C followed by filtering the cooled concentrated suspension to obtain a Tridax procumbens extract.
6. The method as claimed in claim 3, wherein the heating condition in step c) includes temperature ranging from 60 to 100 °C for a time period ranging from……….to……..hrs.
7. The method as claimed in claim 3, wherein the centrifugation in step d) is carried out at a speed ranging from 8000 to 12000 rpm for a time period ranging from 10 to 20 min at a temperature ranging from 15 to 35 °C.
8. The method as claimed in claim 3, wherein the solvent is selected from a group comprising of ethanol, ……………………. and combination thereof.
9. The method as claimed in claim 3, wherein the drying in step f) includes temperature ranging from 60 to 100 °C for a time period ranging from 2 to 6 hrs.
10. The method as claimed in claim 3, wherein the calcination in step f) is carried out at a temperature ranging from 500 to 700 °C for a time period ranging from 1 to 5 hrs.

Documents

Application Documents

# Name Date
1 202541037739-STATEMENT OF UNDERTAKING (FORM 3) [18-04-2025(online)].pdf 2025-04-18
2 202541037739-REQUEST FOR EXAMINATION (FORM-18) [18-04-2025(online)].pdf 2025-04-18
3 202541037739-REQUEST FOR EARLY PUBLICATION(FORM-9) [18-04-2025(online)].pdf 2025-04-18
4 202541037739-FORM-9 [18-04-2025(online)].pdf 2025-04-18
5 202541037739-FORM FOR SMALL ENTITY(FORM-28) [18-04-2025(online)].pdf 2025-04-18
6 202541037739-FORM 1 [18-04-2025(online)].pdf 2025-04-18
7 202541037739-EVIDENCE FOR REGISTRATION UNDER SSI(FORM-28) [18-04-2025(online)].pdf 2025-04-18
8 202541037739-EVIDENCE FOR REGISTRATION UNDER SSI [18-04-2025(online)].pdf 2025-04-18
9 202541037739-EDUCATIONAL INSTITUTION(S) [18-04-2025(online)].pdf 2025-04-18
10 202541037739-DRAWINGS [18-04-2025(online)].pdf 2025-04-18
11 202541037739-DECLARATION OF INVENTORSHIP (FORM 5) [18-04-2025(online)].pdf 2025-04-18
12 202541037739-COMPLETE SPECIFICATION [18-04-2025(online)].pdf 2025-04-18
13 202541037739-FORM 18 [21-04-2025(online)].pdf 2025-04-21
14 202541037739-CORRESPONDENCE-OTHERS [11-05-2025(online)].pdf 2025-05-11
15 202541037739-Proof of Right [26-05-2025(online)].pdf 2025-05-26
16 202541037739-FORM-26 [16-07-2025(online)].pdf 2025-07-16
17 202541037739-RELEVANT DOCUMENTS [17-07-2025(online)].pdf 2025-07-17
18 202541037739-MARKED COPIES OF AMENDEMENTS [17-07-2025(online)].pdf 2025-07-17
19 202541037739-FORM 13 [17-07-2025(online)].pdf 2025-07-17
20 202541037739-AMMENDED DOCUMENTS [17-07-2025(online)].pdf 2025-07-17